Investor insights
Sectors invested in
Funding rounds participated in
$49M sweet spot round size
Most of their 10 investments are in rounds between $15M and $90M
Basic info
Industry
Sectors
Date founded
2019
Investments made
Arialys Therapeutics, Inc. raised $58M on September 12, 2023
Investors: Avalon BioVentures, MPM Capital and Catalys Pacific
Pathalys Pharma raised $150M on January 18, 2023
Investors: DaVita Venture Group, OrbiMed Advisors, The Carlyle Group, Abingworth and Catalys Pacific
Mineralys Therapeutics, Inc. raised $118M on June 8, 2022
Investors: Sectoral Asset Management, HEALTHCOR LTD, Samsara BioCapital, S.R. One Ltd, RA Capital Management, L.P., Ysios Capital, RTW Investments, LP and Catalys Pacific
Aculys Pharma raised $23M on March 28, 2022
Investors: HBM Partners AG, Global Founders Capital, ANRI, 三井住友トラスト・インベストメント（株） and Catalys Pacific
Aculys Pharma raised $60M on October 28, 2021
Investors: Global Founders Capital, SoftBank Investment Advisers, ANRI, HBM Partners AG, 三井住友トラスト・インベストメント（株） and Catalys Pacific
Pathalys Pharma raised $11M on June 22, 2021
Investors: DaVita Venture Group and Catalys Pacific
Mineralys Therapeutics, Inc. raised $4M on April 6, 2021
Investors: Catalys Pacific
Mineralys Therapeutics, Inc. raised $40M on April 6, 2021
Investors: Adams Street Partners, Samsara BioCapital and Catalys Pacific
Undisclosed raised $15M on July 16, 2020
Investors: Domain Associates and Catalys Pacific
Phathom Pharmaceuticals raised $90M on May 15, 2019
Investors: Greenspring Associates, Sahsen Ventures, LLC, Medicxi, Takeda UK Limited, Frazier Healthcare Partners, Richard King Mellon Foundation, RA Capital Management, L.P. and Catalys Pacific